Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE) has a 42-report earnings history dating back to May 19, 2016. Its average absolute post-earnings move is ±3.79%, and 54.8% of those reactions were positive. Its largest post-earnings gain was +14.28% (Feb 19, 2026) and its largest decline was -6.56% (Nov 03, 2022). The next earnings report is predicted for 2026-08-11 (approximate).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
42
Avg Abs. Movement
±3.79%
Positive %
54.8%
Negative %
45.2%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 05, 2026 | ☀ PRE | $70.64 | $73.19 | $71.01 | 51,859 | +2.73% | open_in_new |
| Apr 13, 2026 | ☽ POST | $67.00 | $75.00 | $63.27 | 5,361,100 | +1.17% | open_in_new |
| Feb 19, 2026 | ☽ POST | $36.66 | $38.16 | $37.81 | 803,900 | +14.28% | open_in_new |
| Nov 04, 2025 | ☽ POST | $23.29 | $23.56 | $22.98 | 696,300 | -0.57% | open_in_new |
| Aug 05, 2025 | ☽ POST | $16.15 | $16.99 | $16.87 | 363,500 | -5.39% | open_in_new |
| May 08, 2025 | ☽ POST | $12.56 | $13.41 | $12.86 | 322,500 | +9.64% | open_in_new |
| Feb 27, 2025 | ☽ POST | $19.00 | $19.80 | $18.37 | 925,600 | +7.24% | open_in_new |
| Nov 07, 2024 | ☽ POST | $37.59 | $38.73 | $37.69 | 641,100 | +5% | open_in_new |
| Aug 07, 2024 | ☽ POST | $26.55 | $26.55 | $24.55 | 378,900 | +2.85% | open_in_new |
| May 09, 2024 | ☽ POST | $32.77 | $36.00 | $35.19 | 185,700 | +4.94% | open_in_new |
| Feb 29, 2024 | ☽ POST | $26.45 | $28.80 | $27.44 | 1,169,800 | +8.97% | open_in_new |
| Nov 09, 2023 | ☽ POST | $9.76 | $9.83 | $9.47 | 15,200 | +0.21% | open_in_new |
| Aug 11, 2023 | ☀ PRE | $11.95 | $13.12 | $12.50 | 11,672 | -4.76% | open_in_new |
| May 11, 2023 | ☀ PRE | $4.03 | $4.12 | $3.95 | 14,392 | -3.66% | open_in_new |
| Mar 02, 2023 | ☀ PRE | $9.97 | $11.50 | $9.75 | 8,612 | -1.27% | open_in_new |
| Nov 03, 2022 | ☀ PRE | $30.00 | $30.00 | $28.50 | 33,564 | -6.56% | open_in_new |
| Aug 04, 2022 | ☀ PRE | $10.25 | $10.50 | $10.38 | 11,348 | +6.41% | open_in_new |
| May 05, 2022 | ☀ PRE | $37.50 | $40.75 | $39.50 | 42,856 | +1.28% | open_in_new |
| Mar 08, 2022 | ☀ PRE | $53.75 | $62.50 | $60.50 | 29,700 | +3.86% | open_in_new |
| Nov 04, 2021 | ☀ PRE | $186.50 | $195.12 | $191.50 | 2,856 | -1.03% | open_in_new |
| Aug 05, 2021 | ☀ PRE | $166.25 | $170.75 | $170.25 | 3,980 | +3.18% | open_in_new |
| May 10, 2021 | ☀ PRE | $180.50 | $185.00 | $176.00 | 5,880 | -2.76% | open_in_new |
| Mar 18, 2021 | ☀ PRE | $192.25 | $195.25 | $187.00 | 5,420 | -3.61% | open_in_new |
| Nov 05, 2020 | ☀ PRE | $198.20 | $214.75 | $214.00 | 7,920 | +8.08% | open_in_new |
| Aug 10, 2020 | ☀ PRE | $174.25 | $176.50 | $169.25 | 14,008 | -3.01% | open_in_new |
| May 07, 2020 | ☀ PRE | $194.00 | $201.25 | $196.75 | 12,420 | +5.5% | open_in_new |
| Feb 24, 2020 | ☀ PRE | $187.50 | $189.25 | $185.50 | 3,044 | -5.72% | open_in_new |
| Nov 06, 2019 | ☀ PRE | $203.75 | $203.75 | $201.25 | 752 | -2.07% | open_in_new |
| Aug 06, 2019 | ☀ PRE | $200.75 | $204.25 | $197.75 | 5,016 | -2.83% | open_in_new |
| May 07, 2019 | ☀ PRE | $173.25 | $175.00 | $169.50 | 3,644 | -3.14% | open_in_new |
| Mar 07, 2019 | ☽ POST | $201.25 | $206.00 | $205.00 | 3,580 | -2.44% | open_in_new |
| Nov 08, 2018 | ☀ PRE | $219.25 | $240.00 | $238.00 | 7,396 | +4.85% | open_in_new |
| Aug 09, 2018 | ☀ PRE | $222.75 | $243.75 | $239.50 | 5,488 | +5.86% | open_in_new |
| May 08, 2018 | ☀ PRE | $246.50 | $253.45 | $249.50 | 8,948 | +1.01% | open_in_new |
| Mar 13, 2018 | ☀ PRE | $212.50 | $217.75 | $215.50 | 2,852 | +0.23% | open_in_new |
| Nov 07, 2017 | ☽ POST | $124.25 | $129.25 | $121.25 | 708 | -3.71% | open_in_new |
| Aug 09, 2017 | ☽ POST | $78.50 | $79.25 | $74.50 | 6,552 | +0.34% | open_in_new |
| May 09, 2017 | ☀ PRE | $159.25 | $159.25 | $156.00 | 1,120 | -2.95% | open_in_new |
| Mar 23, 2017 | ☽ POST | $195.25 | $195.25 | $183.00 | 3,320 | +0.68% | open_in_new |
| Nov 09, 2016 | ☀ PRE | $143.00 | $148.72 | $146.50 | 172 | -1.84% | open_in_new |
| Aug 09, 2016 | ☀ PRE | $114.75 | $120.50 | $118.50 | 244 | +3.04% | open_in_new |
| May 19, 2016 | ☀ PRE | $175.50 | $193.75 | $184.00 | 1,272 | -0.67% | open_in_new |
Earnings Count
42
Total earnings in dataset
Avg Abs. Movement
±3.79%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 4 | 20260603 | open_in_new SEC.gov |
| 8-K | 20260601 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
Frequently asked about SYRE earnings
When does Spyre Therapeutics, Inc. report earnings next? expand_more
Spyre Therapeutics, Inc. (SYRE)'s next earnings date is approximate for 2026-08-11. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does SYRE stock move after earnings? expand_more
Over 42 reports, SYRE has moved an average of ±3.79% the session after earnings, closing higher 54.8% of the time.
What was SYRE's biggest post-earnings move? expand_more
SYRE's largest post-earnings gain on record was +14.28% on Feb 19, 2026, and its largest decline was -6.56% on Nov 03, 2022.
Where can I find Spyre Therapeutics, Inc.'s SEC filings? expand_more
All of Spyre Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right